Cargando…

CD5 levels define functionally heterogeneous populations of naïve human CD4(+) T cells

Studies in murine models show that subthreshold TCR interactions with self‐peptide are required for thymic development and peripheral survival of naïve T cells. Recently, differences in the strength of tonic TCR interactions with self‐peptide, as read‐out by cell surface levels of CD5, were associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Aditi, Lebel, Marie‐Ève, Dong, Mengqi, Fournier, Marilaine, Vobecky, Suzanne J., Haddad, Élie, Delisle, Jean‐Sébastien, Mandl, Judith N., Vrisekoop, Nienke, Melichar, Heather J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251777/
https://www.ncbi.nlm.nih.gov/pubmed/33682083
http://dx.doi.org/10.1002/eji.202048788
Descripción
Sumario:Studies in murine models show that subthreshold TCR interactions with self‐peptide are required for thymic development and peripheral survival of naïve T cells. Recently, differences in the strength of tonic TCR interactions with self‐peptide, as read‐out by cell surface levels of CD5, were associated with distinct effector potentials among sorted populations of T cells in mice. However, whether CD5 can also be used to parse functional heterogeneity among human T cells is less clear. Our study demonstrates that CD5 levels correlate with TCR signal strength in human naïve CD4(+) T cells. Further, we describe a relationship between CD5 levels on naïve human CD4(+) T cells and binding affinity to foreign peptide, in addition to a predominance of CD5(hi) T cells in the memory compartment. Differences in gene expression and biases in cytokine production potential between CD5(lo) and CD5(hi) naïve human CD4(+) T cells are consistent with observations in mice. Together, these data validate the use of CD5 surface levels as a marker of heterogeneity among human naïve CD4(+) T cells with important implications for the identification of functionally biased T‐ cell populations that can be exploited to improve the efficacy of adoptive cell therapies.